Literature DB >> 10815617

The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.

P Akarasereenont1, K Techatrisak, S Chotewuttakorn, A Thaworn.   

Abstract

Prostaglandins (PGs) have numerous cardiovascular and inflammatory effects. Cyclooxygenase (COX), which exists as COX-1 and COX-2 isoforms, is the first enzyme in the pathway in which arachidonic acid is converted to PGs. Prostaglandin E2 (PGE2) exerts a variety of biological activities for the maintenance of local homeostasis in the body. Elucidation of PGE2 involvement in the signalling molecules such as COX could lead to potential therapeutic interventions. Here, we have investigated the effects of PGE2 on the induction of COX-2 in human umbilical vein endothelial cells (HUVEC) treated with interleukin-1beta (IL-1beta 1 ng/ml). COX activity was measured by the production of 6-keto-PGF1alpha, PGE2, PGF2alpha and thromboxane B2 (TXB2) in the presence of exogenous arachidonic acids (10 microM for 10 min) using enzyme immunoassay (EIA). COX-1 and COX-2 protein was measured by immunoblotting using specific antibody. Untreated HUVEC contained only COX-1 protein while IL-1beta treated HUVEC contained COX-1 and COX-2 protein. PGE2 (3 microM for 24h) did not affect on COX activity and protein in untreated HUVEC. Interestingly, PGE2 (3 microM for 24h) can inhibit COX-2 protein, but not COX-1 protein, expressed in HUVEC treated with IL-1beta. This inhibition was reversed by coincubation with forskolin (100 microM). The increased COX activity in HUVEC treated with IL-1beta was also inhibited by PGE2 (0.03, 0.3 and 3 microM for 24h) in a dose-dependent manner. Similarly, forskolin (10, 50 or 100 microM) can also reverse the inhibition of PGE2 on increased COX activity in IL-1beta treated HUVEC. The results suggested that (i) PGE2 can initiate negative feedback regulation in the induction of COX-2 elicited by IL-1beta in endothelial cells, (ii) the inhibition of PGE2 on COX-2 protein and activity in IL-1beta treated HUVEC is mediated by cAMP and (iii) the therapeutic use of PGE2 in the condition which COX-2 has been involved may have different roles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10815617      PMCID: PMC1781816          DOI: 10.1080/09629359990298

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  23 in total

1.  Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide.

Authors:  S H Lee; E Soyoola; P Chanmugam; S Hart; W Sun; H Zhong; S Liou; D Simmons; D Hwang
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

Review 2.  The mode of action of anti-inflammatory drugs.

Authors:  J R Vane; R M Botting
Journal:  Postgrad Med J       Date:  1990       Impact factor: 2.401

3.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.

Authors:  M K O'Banion; V D Winn; D A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 4.  Prostaglandin endoperoxide synthase: structure and catalysis.

Authors:  W L Smith; L J Marnett
Journal:  Biochim Biophys Acta       Date:  1991-04-24

5.  Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.

Authors:  N Nishigaki; M Negishi; A Ichikawa
Journal:  Mol Pharmacol       Date:  1996-10       Impact factor: 4.436

6.  Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells.

Authors:  J A Maier; T Hla; T Maciag
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

7.  Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study.

Authors:  H O Altstaedt; B Berzewski; H K Breddin; W Brockhaus; H D Bruhn; M Cachovan; C Diehm; J Dörrler; C S Franke; J D Gruss
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1993-08       Impact factor: 4.006

8.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

Authors:  J A Mitchell; P Akarasereenont; C Thiemermann; R J Flower; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells.

Authors:  P Akarasereenont; J A Mitchell; I Appleton; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

View more
  13 in total

1.  Increased cyclooxygenase-2 expression and prostaglandin E2 production in pressurized renal medullary interstitial cells.

Authors:  Inge Carlsen; Kaitlin E Donohue; Anja M Jensen; Angela L Selzer; Jie Chen; Dix P Poppas; Diane Felsen; Jørgen Frøkiær; Rikke Nørregaard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-07-07       Impact factor: 3.619

2.  Feedback regulation of cyclooxygenase-2 transcription ex vivo and in vivo.

Authors:  Tomo-O Ishikawa; Naveen Jain; Harvey R Herschman
Journal:  Biochem Biophys Res Commun       Date:  2008-12-04       Impact factor: 3.575

Review 3.  Changes in the immune system in depression and dementia: causal or coincidental effects?

Authors:  Brian E Leonard; Ayemu Myint
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

4.  Involvement of COX-2/PGE2 signalling in hypoxia-induced angiogenic response in endothelial cells.

Authors:  Lixing Zhao; Yeke Wu; Zhenrui Xu; Hui Wang; Zhihe Zhao; Yu Li; Pu Yang; Xing Wei
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

5.  Prostaglandin I2 upregulates the expression of anterior pharynx-defective-1α and anterior pharynx-defective-1β in amyloid precursor protein/presenilin 1 transgenic mice.

Authors:  Pu Wang; Pei-Pei Guan; Jing-Wen Guo; Long-Long Cao; Guo-Biao Xu; Xin Yu; Yue Wang; Zhan-You Wang
Journal:  Aging Cell       Date:  2016-05-30       Impact factor: 9.304

6.  The Effects of Thai Herbal Ha-Rak Formula on COX Isoform Expression in Human Umbilical Vein Endothelial Cells Induced by IL-1β.

Authors:  Titchaporn Palo; Athiwat Thaworn; Phornnapa Charoenkij; Onusa Thamsermsang; Sirikul Chotewuttakorn; Pinpat Tripatara; Tawee Laohapand; Pravit Akarasereenont
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-29       Impact factor: 2.629

7.  Oxidized eicosapentaenoic acids more potently reduce LXRα-induced cellular triacylglycerol via suppression of SREBP-1c, PGC-1β and GPA than its intact form.

Authors:  Tharnath Nanthirudjanar; Hidehiro Furumoto; Takashi Hirata; Tatsuya Sugawara
Journal:  Lipids Health Dis       Date:  2013-05-16       Impact factor: 3.876

8.  PPAR activation induces M1 macrophage polarization via cPLA₂-COX-2 inhibition, activating ROS production against Leishmania mexicana.

Authors:  J A Díaz-Gandarilla; C Osorio-Trujillo; V I Hernández-Ramírez; P Talamás-Rohana
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

9.  Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells.

Authors:  Bryan D Shelby; Heather L LaMarca; Harris E McFerrin; Anne B Nelson; Joseph A Lasky; Gang Sun; Leslie Myatt; Margaret K Offermann; Cindy A Morris; Deborah E Sullivan
Journal:  Virol J       Date:  2007-09-14       Impact factor: 4.099

10.  Prostaglandin I₂ Attenuates Prostaglandin E₂-Stimulated Expression of Interferon γ in a β-Amyloid Protein- and NF-κB-Dependent Mechanism.

Authors:  Pu Wang; Pei-Pei Guan; Xin Yu; Li-Chao Zhang; Ya-Nan Su; Zhan-You Wang
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.